National Institute for Public Health and the Environment (RIVM), Center for Health Protection, Bilthoven, Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Netherlands.
German Centre for The Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment, Berlin, Germany.
Toxicol In Vitro. 2018 Aug;50:62-74. doi: 10.1016/j.tiv.2018.02.018. Epub 2018 Mar 2.
This report describes the proceedings of the BfR-RIVM workshop on validation of alternative methods which was held 23 and 24 March 2017 in Berlin, Germany. Stakeholders from governmental agencies, regulatory authorities, universities, industry and the OECD were invited to discuss current problems concerning the regulatory acceptance and implementation of alternative test methods and testing strategies, with the aim to develop feasible solutions. Classical validation of alternative methods usually involves one to one comparison with the gold standard animal study. This approach suffers from the reductionist nature of an alternative test as compared to the animal study as well as from the animal study being considered as the gold standard. Modern approaches combine individual alternatives into testing strategies, for which integrated and defined approaches are emerging at OECD. Furthermore, progress in mechanistic toxicology, e.g. through the adverse outcome pathway approach, and in computational systems toxicology allows integration of alternative test battery results into toxicity predictions that are more fine-tuned to the human situation. The road towards transition to a mechanistically-based human-focused hazard and risk assessment of chemicals requires an open mind towards stepping away from the animal study as the gold standard and defining human biologically based regulatory requirements for human hazard and risk assessment.
本报告介绍了 2017 年 3 月 23 日至 24 日在德国柏林举行的 BfR-RIVM 替代方法验证研讨会的情况。来自政府机构、监管机构、大学、工业界和经合组织的利益攸关方应邀讨论了关于替代测试方法和测试策略的监管接受和实施的当前问题,目的是制定可行的解决方案。替代方法的经典验证通常涉及与黄金标准动物研究的一对一比较。这种方法存在替代测试的简化性质以及将动物研究视为黄金标准的问题。现代方法将各个替代方法组合成测试策略,经合组织正在为这些策略制定综合和明确的方法。此外,在机制毒理学方面取得了进展,例如通过不良结局途径方法,以及在计算系统毒理学方面的进展,允许将替代测试组合结果整合到对人类情况更精细的毒性预测中。朝着基于机制的以人类为中心的化学品危害和风险评估的转变,需要摒弃将动物研究作为黄金标准的思维模式,并为人类危害和风险评估定义基于人类生物学的监管要求。